Article Information
History
- May 29, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Graziella R. Paniz1,
- Fray M. Arroyo-Mercado1,
- Christina L. Ling1,
- E. Eunice Choi2,
- Harry E. Snow2,
- Neal E. Rakov1 and
- Eliseo F. Castillo*,1,2
- 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
- 2Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
- ↵*Correspondence
Email: ecastillo{at}salud.unm.edu, University of New Mexico, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA., 505-272-5703
Posted May 29, 2021.
Assessment of mesalamine in the alterations of metabolic parameters in comorbid ulcerative colitis and metabolic syndrome patients: A retrospective study
